Conmed (CNMD) Tops Q1 EPS by 8c; Hikes FY22 Revenue Guidance

Conmed (NYSE: CNMD) reported Q1 EPS of $0.70, $0.08 better than the analyst estimate of $0.62. Revenue for the quarter came in at $242.3 million versus the consensus estimate of $235.77 million.

GUIDANCE:

Conmed sees FY2022 revenue of $1.105-1.15 billion, versus the consensus of $1.09 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms